| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.alufluoride.com | |
| Market Cap | 241.22 Cr. | |
| Enterprise Value(EV) | 261.84 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 12.62 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 24.49 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 26.46 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 82.91 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 3.73 | Calculated using Price: 309.00 |
| Dividend Yield | 0.32 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.78 Cr. | 7,820,482 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Alufluoride started a project in 1993 for producing Aluminium Fluoride. The project was completed in record time at a cost of Rs 20 crore. Trial runs commenced in November 1994 and production of high quality commenced during December 1994. Supplies started immediately thereafter to primary aluminium smelters. The company increased production year after year at high quality standards. The company has an installed annual production capacity of 6000 tons of Aluminium Fluoride and plans to expand further. Alufluoride is the only company in Andhra Pradesh, producing Aluminium Fluoride (ALF3) with the modern Fluosilicic Acid technology developed by Alusuisse, Switzerland. | ||
| 1 Day |
|
-0.21% |
| 1 Week |
|
-0.06% |
| 1 Month |
|
+1.13% |
| 3 Month |
|
+16.19% |
| 6 Month |
|
+12.55% |
| 1 Year |
|
+1.93% |
| 2 Year |
|
+30.02% |
| 5 Year |
|
+203.24% |
| 10 Year |
|
+3291.88% |
| 2 years | 2021-03 | 2022-03 | |
| Return on Equity (%) | -1.06 | 6.56 | |
| Return on Capital Employed (%) | -0.19 | 9.94 | |
| Return on Assets (%) | -0.58 | 3.62 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 52 | 56 | 60 | |
| Non Curr. Liab. | 30 | 27 | 27 | |
| Curr. Liab. | 13 | 18 | 23 | |
| Minority Int. | ||||
| Equity & Liab. | 95 | 100 | 110 | |
| Non Curr. Assets | 69 | 67 | 69 | |
| Curr. Assets | 26 | 33 | 41 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 95 | 100 | 110 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 39 | 88 | 130 | |
| Other Income | 1 | 1 | 1 | |
| Total Income | 39 | 89 | 131 | |
| Total Expenditure | -37 | -75 | -107 | |
| PBIDT | 2 | 14 | 24 | |
| Interest | -1 | -3 | -3 | |
| Depreciation | -3 | -6 | -7 | |
| Taxation | 1 | -1 | -4 | |
| Exceptional Items | ||||
| PAT | -1 | 4 | 10 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | -1 | 4 | 10 | |
| Adjusted EPS | -1 | 5 | 13 |
| Particulars | 2 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 4 | |
| Cash Fr. Inv. | -11 | -6 | |
| Cash Fr. Finan. | 16 | -5 | |
| Net Change | 2 | -7 | |
| Cash & Cash Eqvt | 8 | 2 |
|
Mon, 30 Jan 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30Th January 2023. In reference to our earlier intimation dated 19th January 2023 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations 2015 this is to inform you that the Board of Directors at its meeting held today i.e. 30th January 2023 has inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2022. Accordingly we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.20 P.M. |
|
Mon, 30 Jan 2023
Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2022. In reference to our earlier intimation dated 19th January 2023 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations 2015 this is to inform you that the Board of Directors at its meeting held today i.e. 30th January 2023 has inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2022.Accordingly we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2022 along with the Limited Review Report of the Statutory Auditors of the Company.The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.20 P.M. |
|
Thu, 19 Jan 2023
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2022. ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2022. |
| Fri, 24 Mar 2023 |
High Delivery Percentage
|
Opening at High
|
Close Within 52 Week High Zone
|
High Increase in 3 Months
|
High Increase in 5 Years
|
Equities
M.F.
Sectors